Implication of alpha-lipoic acid preparations in the treatment of diabetic neuropathy
Al'-Zamil', M.Kh.; Brezheva, E.V.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(2): 27-30
2008
ISSN/ISBN: 1997-7298 PMID: 18427500 Document Number: 620826
Twenty-eight patients, 17 women and 11 men, aged 40-70 years, with distal sensory-motor diabetic neuropathy of the lower extremities were treated with berlition, an alpha-lipoic acid preparation, in dosage 600 mg daily during 3 months. The treatment resulted in the significant reduction of clinical (sensory and motor) and neurological changes of lower extremity peripheral nerves.
Document emailed within 1 workday
Related Documents
1994: Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy Der Internist 35(6 Alpha-Liponsa): 1-4Becić, F.; Kapić, E.; Rakanović-Todić, M. 2008: Pharmacological significance of alpha lipoic acid in up to date treatment of diabetic neuropathy Medicinski Arhiv 62(1): 45-48
Al-Zamil, M.Kh. 2008: The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(7): 23-26
Tankova, T.; Koev, D.; Dakovska, L. 2004: Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study) Romanian Journal of Internal Medicine 42(2): 457-464
Vereşiu, I.A. 2004: Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based Romanian Journal of Internal Medicine 42(2): 293-299
Loginov, A.S.; Nilova, T.V.; Bendikov, E.A.; Petrakov, A.V. 1990: Preparations of alpha-lipoic acid: the dynamics of their content in the blood and their effect on hemostasis in lesions of the human liver Farmakologiia i Toksikologiia 53(2): 47-50
Volchegorskiĭ, I.A.; Alekseev, M.N.; Volchegorskaia, M.I.; Rassokhina, L.M. 2008: Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome Klinicheskaia Meditsina 86(10): 52-59
Ametov, A.S.; Novosadova, M.V.; Barinov, A.N.; Samigullin, R.; Trischler, H.-J.ür. 2010: Long-term effect of 3-week intravenous alpha-lipoic acid administration in symptomatic diabetic polyneutropathy with clinical manifestations Terapevticheskii Arkhiv 82(12): 61-64
Dudchenko, N.O.; Mykhaĭlik, O.M.; Lubianova, I.P. 2001: Effect of alpha-lipoic acid preparations on bilirubin and transferrin levels and ferritin iron and transferrin iron content Ukrains'kyi Biokhimichnyi Zhurnal 73(2): 102-105
Battisti, E.; Albanese, A.; Guerra, L.; Argnani, L.; Giordano, N. 2013: Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain European Journal of Physical and Rehabilitation Medicine 49(5): 659-664
Maglione, E.; Marrese, C.; Migliaro, E.; Marcuccio, F.; Panico, C.; Salvati, C.; Citro, G.; Quercio, M.; Roncagliolo, F.; Torello, C.; Brufani, M. 2015: Increasing bioavailability of (R)-alpha-lipoic acid to boost antioxidant activity in the treatment of neuropathic pain Acta Bio-Medica: Atenei Parmensis 86(3): 226-233
González-Pérez, O.; Moy-López, N.Angélica.; Guzmán-Muñiz, J. 2008: Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 60(1): 58-67
Jamal, G.A. 1994: The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy Diabetic Medicine: a Journal of the British Diabetic Association 11(2): 145-149
Vorob'eva, O.V. 2011: Thioctic (alpha-lipoic) acid-spectrum of clinical use Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(10 Part 1): 86-90
Machoy, Z.; Chmielewski, K. 1970: Experimental studies of oxidation-reduction properties of alpha-lipoic acid Annales Academiae Medicae Stetinensis 16: 145-159
Loginow, A.S. 1970: Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 30(1): 19-23
Jacob, S.; Henriksen, E.J.; Schiemann, A.L.; Simon, I.; Clancy, D.E.; Tritschler, H.J.; Jung, W.I.; Augustin, H.J.; Dietze, G.J. 1995: Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid Arzneimittel-Forschung 45(8): 872-874
Jayanthi, S.; Varalakshmi, P. 1992: Tissue lipids in experimental calcium oxalate lithiasis and the effect of DL alpha-lipoic acid Biochemistry International 26(5): 913-921
Vidović, B.; Milovanović, Sđan.; Dorđević, Bžita.; Kotur-Stevuljević, J.; Stefanović, A.; Ivanišević, J.; Miljković, M.; Spasić, S.; Stojanović, D.; Pantović, M. 2014: Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with schizophrenia Psychiatria Danubina 26(3): 205-213
Pack, R.A.; Hardy, K.; Madigan, M.C.; Hunt, N.H. 2002: Differential effects of the antioxidant alpha-lipoic acid on the proliferation of mitogen-stimulated peripheral blood lymphocytes and leukaemic T cells Molecular Immunology 38(10): 733-745